Lansoprazole

兰索拉唑

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameLansoprazole
Drug Alias NameTakepron OD Tablets 15达克普隆PrezalEstomilIlsatec +[29] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsHelicobacter pylori infectionHeartburnObesity +[18] 
Global Approved IndicationsDuodenal UlcerPeptic UlcerEsophagitis +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals USA IncTanta UniversityTakeda Pharmaceutical Co Ltd +[8] 
Inactive CompaniesUtah State UniversityThe University Of California DavisTakeda Pharms Na +[10] 
Active IndicationsStomach UlcerDuodenal UlcerPeptic Ulcer +[7] 
Inactive IndicationsHelicobacter pylori infectionHeartburnObesity +[11] 

Other Information

ATC CodeA02BC03
Related LinksN/A